(0.25%) 5 144.25 points
(0.26%) 38 541 points
(0.35%) 17 909 points
(-0.81%) $83.17
(1.25%) $1.947
(-0.08%) $2 345.40
(0.29%) $27.62
(0.89%) $930.30
(-0.27%) $0.932
(-0.33%) $10.99
(-0.38%) $0.797
(0.87%) $92.67
0.46% INR 1 198.00
Live Chart Being Loaded With Signals
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India...
Stats | |
---|---|
Today's Volume | 3 189.00 |
Average Volume | 13 224.00 |
Market Cap | 6.84B |
EPS | INR0 ( 2024-02-05 ) |
Next earnings date | ( INR0 ) 2024-05-13 |
Last Dividend | INR9.00 ( 2023-08-02 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 10.32 |
ATR14 | INR3.90 (0.32%) |
Volume Correlation
Albert David Limited Correlation
10 Most Positive Correlations | |
---|---|
KOTAKBANK.NS | 0.872 |
TARC.NS | 0.85 |
BOROLTD.NS | 0.847 |
CROWN.NS | 0.819 |
MAXVIL.NS | 0.811 |
DLF.NS | 0.807 |
10 Most Negative Correlations | |
---|---|
GANGOTRI.NS | -0.845 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Albert David Limited Correlation - Currency/Commodity
Albert David Limited Financials
Annual | 2022 |
Revenue: | INR3.42B |
Gross Profit: | INR2.18B (63.96 %) |
EPS: | INR63.39 |
FY | 2022 |
Revenue: | INR3.42B |
Gross Profit: | INR2.18B (63.96 %) |
EPS: | INR63.39 |
FY | 2022 |
Revenue: | INR3.12B |
Gross Profit: | INR1.95B (62.39 %) |
EPS: | INR61.78 |
FY | 2021 |
Revenue: | INR2.46B |
Gross Profit: | INR1.58B (64.26 %) |
EPS: | INR38.80 |
Financial Reports:
No articles found.
Albert David Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR18.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR9.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR5.50 | 2017-09-01 |
Last Dividend | INR9.00 | 2023-08-02 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | INR57.00 | -- |
Avg. Dividend % Per Year | 1.24% | -- |
Score | 2.27 | -- |
Div. Sustainability Score | 3.59 | |
Div.Growth Potential Score | 4.35 | |
Div. Directional Score | 3.97 | -- |
Year | Amount | Yield |
---|---|---|
2017 | INR0 | 0.00% |
2018 | INR5.50 | 1.47% |
2019 | INR6.00 | 1.45% |
2020 | INR7.00 | 1.69% |
2021 | INR6.00 | 1.33% |
2022 | INR18.00 | 2.67% |
2023 | INR9.00 | 1.57% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SHYAMMETL.NS | Dividend Junior | 2023-06-05 | Semi-Annually | 4 | 0.70% | |
MAXHEALTH.NS | Dividend Junior | 2023-09-08 | Insufficient data to determine frequency | 2 | 0.07% | |
GSPL.NS | Dividend Junior | 2023-09-01 | Annually | 19 | 0.81% | |
BANKINDIA.NS | Dividend Junior | 2023-06-20 | Sporadic | 23 | 1.34% | |
PRAJIND.NS | Dividend Junior | 2023-07-19 | Annually | 22 | 0.83% | |
KABRAEXTRU.NS | Dividend Junior | 2023-07-13 | Annually | 23 | 0.83% | |
DVL.NS | Dividend Junior | 2023-09-13 | Annually | 17 | 1.37% | |
ADANIENT.NS | Dividend Junior | 2023-07-06 | Annually | 23 | 0.08% | |
STARPAPER.NS | Dividend Junior | 2023-09-15 | Sporadic | 22 | 1.19% | |
MUNJALAU.NS | Dividend Junior | 2023-08-24 | Sporadic | 19 | 1.47% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.187 | 1.500 | 6.27 | 9.40 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.200 | 1.500 | 8.89 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 187.43 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 25.56 | 2.00 | 1.479 | 2.96 | [0 - 30] |
freeCashFlowPerShareTTM | 25.56 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.643 | 1.000 | 2.61 | 2.61 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.193 | 1.000 | 8.13 | 8.13 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.59 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.27 | 1.000 | 9.06 | 0 | [1 - 100] |
returnOnEquityTTM | 0.200 | 2.50 | 9.28 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 25.56 | 2.00 | 1.479 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.755 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 25.56 | 2.00 | 1.479 | 2.96 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 3.94 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0411 | 1.000 | -1.472 | 0 | [0.1 - 0.5] |
Total Score | 4.35 |
Albert David Limited
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators